Home » Topics » Regulatory

Regulatory
RSS

Adolor receives additional patent protection for ADL-2-1294

Jan. 21, 1999

Adolor receives patent protection for novel approach to analgesia

Jan. 21, 1999

FDA committee does not recommend approval of Prograf for GVHD

Jan. 21, 1999

Generic form of Ritalin approved by FDA

Jan. 20, 1999

Results from large study comparing atovaquone and dapsone for PCP prophylaxis published

Jan. 19, 1999

New indication approved for Livial, a tissue-specific treatment for menopausal symptoms

Jan. 19, 1999

CLASS study evaluates clomethiazole in acute stroke patients

Jan. 18, 1999

Tianeptine, a 5-HT uptake enhancer, demonstrates excellent efficacy in asthma

Jan. 15, 1999

Amantadine reverses adverse effects of neuroleptic drugs on sexual function in males

Jan. 15, 1999

Seretide cleared for marketing in most E.U. countries

Jan. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.